Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Litzow

Blood

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Blood|April 18, 2015
Finally moving forward in adult ALLMark R Litzow
Blood|May 14, 2015
How I treat T-cell acute lymphoblastic leukemia in adultsMark R Litzow, Adolfo A Ferrando
Blood|September 22, 2012
AML cytogenetics: the complex just got simplerHillard M Lazarus, Mark R Litzow
Blood|September 5, 2024
Incorporation of immunotherapy into frontline treatment for adults with B-cell precursor acute lymphoblastic leukemiaTalha Badar, Selina M Luger, Mark R Litzow
Blood|September 16, 2006
Hematologic manifestations of celiac diseaseThorvardur R Halfdanarson, Mark R Litzow, Joseph A Murray
Blood|April 22, 2004
Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivoAllan B Dietz, Lina Souan, Gaylord J Knutson, et al.
Blood|October 3, 2007
Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia predicts superior relapse-free survivalMichelle A Elliott, Mark R Litzow, Louis L Letendre, et al.
Blood|June 25, 2005
Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapyMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Blood|August 19, 2010
Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999Larry D Cripe, Hajime Uno, Elisabeth M Paietta, et al.
Blood|March 19, 2011
Autologous transplantation gives encouraging results for young adults with favorable-risk acute myeloid leukemia, but is not improved with gemtuzumab ozogamicinHugo F Fernandez, Zhuoxin Sun, Mark R Litzow, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Blood|April 18, 2015
Finally moving forward in adult ALLMark R Litzow
Blood|May 14, 2015
How I treat T-cell acute lymphoblastic leukemia in adultsMark R Litzow, Adolfo A Ferrando
Blood|September 22, 2012
AML cytogenetics: the complex just got simplerHillard M Lazarus, Mark R Litzow
Blood|September 5, 2024
Incorporation of immunotherapy into frontline treatment for adults with B-cell precursor acute lymphoblastic leukemiaTalha Badar, Selina M Luger, Mark R Litzow
Blood|September 16, 2006
Hematologic manifestations of celiac diseaseThorvardur R Halfdanarson, Mark R Litzow, Joseph A Murray
Blood|April 22, 2004
Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivoAllan B Dietz, Lina Souan, Gaylord J Knutson, et al.
Blood|October 3, 2007
Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia predicts superior relapse-free survivalMichelle A Elliott, Mark R Litzow, Louis L Letendre, et al.
Blood|June 25, 2005
Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapyMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Blood|August 19, 2010
Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999Larry D Cripe, Hajime Uno, Elisabeth M Paietta, et al.
Blood|March 19, 2011
Autologous transplantation gives encouraging results for young adults with favorable-risk acute myeloid leukemia, but is not improved with gemtuzumab ozogamicinHugo F Fernandez, Zhuoxin Sun, Mark R Litzow, et al.
Pageof 5